The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has released a Form 8.3 regarding its interests in Mural Oncology plc. This disclosure follows the guidelines of the Irish Takeover Panel. As of 21 July 2025, Vanguard held 772,563 ordinary shares, accounting for 4.47% of Mural Oncology's relevant securities.

The statement also confirms a recent sale of 16 ordinary shares at a price of 2.48 USD each. No additional dealings, such as cash-settled or stock-settled derivatives, were reported. Furthermore, there are no existing indemnities or other arrangements related to these securities.

This disclosure emphasizes that Vanguard currently does not have any agreements or understandings concerning options or derivatives connected to Mural Oncology.